Myeloproliferative Neoplasms

Myeloproliferative Neoplasms: How Do MPNs Affect Quality of Life?

By

Tom Greenhalgh

Publish Date September 16, 2021

As myeloproliferative neoplasms (MPNs) are a rare form of blood cancer, patients may not be aware of its effects. How do MPNs affect a patient’s quality of life, and what do your patients need to know?

Study Identifies Characteristics Associated With Cerebral Venous Thrombosis in Patients With Myeloproliferative Neoplasms

By

Vicki Moore, PhD

Publish Date September 10, 2021

Researchers characterized incidence and factors linked to cerebral venous thrombosis associated with myeloproliferative neoplasms.

Disease Features in Young Patients With Myeloproliferative Neoplasms

By

Vicki Moore, PhD

Publish Date August 17, 2021

Researchers found a high incidence of thromboembolic events in young patients with myeloproliferative neoplasms, especially polycythemia vera.

Patients With MPN and Their Caregivers Could Benefit from Greater Support, Interventions

By

Jennifer Larson

Publish Date July 13, 2021

During a residential rehabilitation program, researchers interviewed participants to determine their supportive care and rehabilitation needs.

Staging Criteria for Advanced Systemic Mastocytosis Updated in the Era of KIT Inhibitors

By

Jessica Nye, PhD

Publish Date June 14, 2021

The updated criteria from IWG-MRT-ECNM extended previous criteria to describe organ-by-organ specific response and progression cut-offs.